HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanhong Shi Selected Research

Yanhong Shi Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 01/2012
6Inflammation (Inflammations)
01/2020 - 01/2015
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2012
3Infections
01/2022 - 01/2021
3Carcinogenesis
01/2021 - 01/2017
3Ulcerative Colitis
01/2020 - 01/2018
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2018 - 01/2015
2Canavan Disease (Leukodystrophy, Spongiform)
06/2022 - 12/2020
2Hepatocellular Carcinoma (Hepatoma)
05/2022 - 01/2019
2COVID-19
01/2022 - 01/2021
2Disease Progression
11/2020 - 02/2015
2Sepsis (Septicemia)
01/2020 - 01/2018
2Neurodevelopmental Disorders
03/2016 - 06/2015
2Schizophrenia (Dementia Praecox)
03/2016 - 06/2015
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2008 - 06/2007
1Epiretinal Membrane (Epiretinal Membranes)
01/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Retinal Perforations
01/2021
1Demyelinating Diseases (Demyelinating Disease)
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Shock
01/2020
1Microcephaly
01/2019
1Crohn Disease (Crohn's Disease)
12/2018
1Colitis
01/2018
1Necrosis
06/2017
1Hypertension (High Blood Pressure)
06/2017
1Alexander Disease (Alexander's Disease)
01/2016
1Adenoma (Adenomas)
10/2015
1Bipolar Disorder (Manic Depressive Psychosis)
06/2015
1Neoplasm Metastasis (Metastasis)
02/2015
1Breast Neoplasms (Breast Cancer)
02/2015

Drug/Important Bio-Agent (IBA)

4MicroRNAs (MicroRNA)IBA
03/2016 - 01/2012
2Peptides (Polypeptides)IBA
01/2020 - 12/2018
26-methyladenineIBA
01/2019 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 10/2015
2Proteins (Proteins, Gene)FDA Link
06/2017 - 01/2016
2Messenger RNA (mRNA)IBA
06/2017 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2017 - 06/2015
1Tumor Biomarkers (Tumor Markers)IBA
05/2022
1Fetal Proteins (Fetoprotein)IBA
05/2022
1LuciferasesIBA
01/2022
1pseudouridine synthasesIBA
01/2021
1remdesivirIBA
01/2021
1Apolipoprotein E4IBA
01/2021
1Apolipoprotein E3IBA
01/2021
1Transfer RNA (tRNA)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1ErythropoietinFDA Link
01/2021
1Ranibizumab (Lucentis)FDA Link
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1PseudouridineIBA
01/2021
1aspartoacylaseIBA
12/2020
1N-acetylaspartate (N-acetyl aspartate)IBA
12/2020
1apatinibIBA
11/2020
1Pemetrexed (MTA)FDA Link
11/2020
1Docetaxel (Taxotere)FDA Link
11/2020
1ChlorotoxinIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1antiglomerular basement membrane antibodyIBA
01/2020
1AntigensIBA
01/2020
1banlangenIBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2020
1Centrosomal Associated ProteinsIBA
01/2019
1Immunoglobulin G (IgG)IBA
12/2018
1C-Reactive ProteinIBA
12/2018
1Immunoglobulins (Immunoglobulin)IBA
12/2018
1Immunoglobulin A (IgA)IBA
12/2018
1Cisplatin (Platino)FDA LinkGeneric
12/2018
1Protein Isoforms (Isoforms)IBA
12/2018
1Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2018
1Dosage Forms (Dosage Form)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
12/2018
1Dextran SulfateIBA
01/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018
1XuebijingIBA
01/2018
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2018
1CytokinesIBA
01/2018
1Therapeutic UsesIBA
06/2017
1Adrenomedullin ReceptorsIBA
06/2017
1Chemotactic FactorsIBA
06/2017
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
06/2017
1Heme (Haem)IBA
06/2017
1MethyltransferasesIBA
01/2017
1N-methyladenosineIBA
01/2017
1OvalbuminIBA
12/2015
1InterleukinsIBA
12/2015
1Calcibiotic Root Canal SealerIBA
10/2015
1Pyruvate KinaseIBA
02/2015
1EnzymesIBA
02/2015
1Glucose (Dextrose)FDA LinkGeneric
02/2015

Therapy/Procedure

9Therapeutics
06/2022 - 01/2008
2Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2018 - 01/2018
1Intravitreal Injections
01/2021
1Vitrectomy
01/2021
1Drug Therapy (Chemotherapy)
11/2020
1Injections
01/2018
1Immunotherapy
12/2015